After neoadjuvant chemoradiotherapy, robotic esophagectomy lowers blood loss and hospital stay without worsening oncologic results or complications, according to a meta-analysis of seven studies.
- Across 2,395 patients, robotic surgery (RAMIE) reduced blood loss by about 26 mL and stay by about 1.8 days versus conventional minimally invasive surgery (CMIE).
- Lymph node yield was higher with the robot, by about 2.6 nodes.
Robotic esophagectomy is a reasonable minimally invasive option after neoadjuvant chemoradiotherapy, since pathologic complete response, R0 resection, anastomotic leak, and 30- and 90-day mortality were similar. The included studies were observational, so the benefits are associations, not proven causes.
Journal Article by Bertch A, Douri D (…) Pansegrau T et 2 al. in Surg Endosc
© 2026. The Author(s).